These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32881862)

  • 1. A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies.
    Hotez PJ; Bush K; Oswald A; Rockman G; Lim IT; Jee Y; Moon CJ; Kim JH; Kim Y
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0007956. PubMed ID: 32881862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Industry, Academia and Government Partnership through the Global Health Innovative Technology Fund (GHIT)].
    Hinoshita E
    Yakugaku Zasshi; 2016; 136(2):237-42. PubMed ID: 26831799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Health Innovative Technology (GHIT) Fund: financing medical innovations for neglected populations.
    Slingsby BT; Kurokawa K
    Lancet Glob Health; 2013 Oct; 1(4):e184-5. PubMed ID: 25104343
    [No Abstract]   [Full Text] [Related]  

  • 4. Global coalition chips away at neglected tropical diseases.
    Maxmen A
    Nature; 2017 Apr; 544(7650):281-282. PubMed ID: 28426009
    [No Abstract]   [Full Text] [Related]  

  • 5. RRR for NNN-a rapid research response for the Neglected Tropical Disease NGDO Network: a novel framework to challenges faced by the global programs targeting neglected tropical diseases.
    Toledo CE; Jacobson J; Wainwright EC; Ottesen EA; Lammie PJ
    Int Health; 2016 Mar; 8 Suppl 1(Suppl 1):i12-4. PubMed ID: 26940303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
    Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
    Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Straight talk with...BT Slingsby. Interviewed by Cassandra Willyard.
    Slingsby BT
    Nat Med; 2013 Dec; 19(12):1553. PubMed ID: 24309642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why Funding for Neglected Tropical Diseases Should Be a Global Priority.
    Reed SL; McKerrow JH
    Clin Infect Dis; 2018 Jul; 67(3):323-326. PubMed ID: 29688342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hit and lead criteria in drug discovery for infectious diseases of the developing world.
    Katsuno K; Burrows JN; Duncan K; Hooft van Huijsduijnen R; Kaneko T; Kita K; Mowbray CE; Schmatz D; Warner P; Slingsby BT
    Nat Rev Drug Discov; 2015 Nov; 14(11):751-8. PubMed ID: 26435527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fund global health: Save lives and money.
    Galvani AP; Fitzpatrick MC; Vermund SH; Singer BH
    Science; 2017 Jun; 356(6342):1018-1019. PubMed ID: 28596330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who Neglects Neglected Tropical Diseases? - Korean Perspective.
    Choi MH; Yu JR; Hong ST
    J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S122-30. PubMed ID: 26617444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. END7--reinvigorating elimination of neglected diseases.
    Hayward P
    Lancet Infect Dis; 2014 Feb; 14(2):104-5. PubMed ID: 24605380
    [No Abstract]   [Full Text] [Related]  

  • 13. Spurring new research for neglected diseases.
    Anderson GF
    Health Aff (Millwood); 2009; 28(6):1750-9. PubMed ID: 19887416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japan's innovation for global health - GHIT's catalytic role.
    Katsuno K
    Parasitol Int; 2021 Feb; 80():102232. PubMed ID: 33144196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development assistance for neglected tropical diseases: progress since 2009.
    Liese BH; Houghton N; Teplitskaya L
    Int Health; 2014 Sep; 6(3):162-71. PubMed ID: 25096331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative financing for late-stage global health research and development: the Global Health Investment Fund.
    Fitchett JR; Fan Li J; Atun R
    Int Health; 2016 Jan; 8(1):3-4. PubMed ID: 26612852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the US priority review voucher on private-sector investment in global health research and development.
    Robertson AS; Stefanakis R; Joseph D; Moree M
    PLoS Negl Trop Dis; 2012; 6(8):e1750. PubMed ID: 22953004
    [No Abstract]   [Full Text] [Related]  

  • 19. New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI).
    Hotez PJ
    PLoS Negl Trop Dis; 2011; 5(5):e1133. PubMed ID: 21655348
    [No Abstract]   [Full Text] [Related]  

  • 20. Blue marble health: a call for papers.
    Hotez PJ; Peiperl L
    PLoS Med; 2014 Jul; 11(7):e1001682. PubMed ID: 25072140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.